Literature DB >> 14562056

Five new mouse susceptibility to colon cancer loci, Scc11-Scc15.

Claudia A L Ruivenkamp1, Tamás Csikós, Anita M Klous, Tom van Wezel, Peter Demant.   

Abstract

Although several genes causing familial cancer syndromes have been identified, susceptibility to sporadic cancer remains unsolved. Animal experiments have demonstrated a large number of quantitative trait loci affecting cancer susceptibility. Previously, we described in mouse strain CcS-19/Dem five susceptibility to colon cancer (Scc) loci, Scc1-Scc5 controlling tumor numbers. In the present study, we performed an independent identical mouse cross using a distinct carcinogen, azoxymethane, to induce colon tumors. We confirmed all five originally described Scc loci and detected five additional new Scc loci; Scc11-Scc15. All these loci were detected in two-way interactions.

Entities:  

Mesh：

Year:  2003        PMID： 14562056     DOI： 10.1038/sj.onc.1207096

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  12 in total

1.  Bayesian multiple quantitative trait loci mapping for complex traits using markers of the entire genome.

Authors:  Hanwen Huang; Chevonne D Eversley; David W Threadgill; Fei Zou
Journal:  Genetics       Date:  2007-05-04       Impact factor: 4.562

2.  Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.

Authors:  Stephanie C Nnadi; Rayneisha Watson; Julie Innocent; Gregory E Gonye; Arthur M Buchberg; Linda D Siracusa
Journal:  Carcinogenesis       Date:  2012-05-24       Impact factor: 4.944

3.  Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats.

Authors:  Lei Quan; Alphons P M Stassen; Claudia A L Ruivenkamp; Tom van Wezel; Remond J A Fijneman; Alan Hutson; Neelima Kakarlapudi; Augustinus A M Hart; Peter Demant
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

4.  Mapping hyper-susceptibility to colitis-associated colorectal cancer in FVB/NJ mice.

Authors:  Lauren Van Der Kraak; David Langlais; Serge Jothy; Nicole Beauchemin; Philippe Gros
Journal:  Mamm Genome       Date:  2016-03-15       Impact factor: 2.957

Review 5.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.

Authors:  Matthew A Dale; Melissa K Suh; Shijia Zhao; Trevor Meisinger; Linxia Gu; Vicki J Swier; Devendra K Agrawal; Timothy C Greiner; Jeffrey S Carson; B Timothy Baxter; Wanfen Xiong
Journal:  Atherosclerosis       Date:  2015-10-08       Impact factor: 5.162

7.  Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.

Authors:  Alicia G Cleveland; Seija I Oikarinen; Kimberly K Bynoté; Maija Marttinen; Joseph J Rafter; Jan-Ake Gustafsson; Shyamal K Roy; Henry C Pitot; Kenneth S Korach; Dennis B Lubahn; Marja Mutanen; Karen A Gould
Journal:  Carcinogenesis       Date:  2009-06-11       Impact factor: 4.944

Review 8.  Colitis-associated colon cancer: Is it in your genes?

Authors:  Lauren Van Der Kraak; Philippe Gros; Nicole Beauchemin
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Mapping six new susceptibility to colon cancer (Scc) loci using a mouse interspecific backcross.

Authors:  Chevonne D Eversley; Xie Yuying; R Scott Pearsall; David W Threadgill
Journal:  G3 (Bethesda)       Date:  2012-12-01       Impact factor: 3.154

10.  Positional mapping and candidate gene analysis of the mouse Ccs3 locus that regulates differential susceptibility to carcinogen-induced colorectal cancer.

Authors:  Charles Meunier; Lauren Van Der Kraak; Claire Turbide; Normand Groulx; Ingrid Labouba; Pablo Cingolani; Mathieu Blanchette; Garabet Yeretssian; Anne-Marie Mes-Masson; Maya Saleh; Nicole Beauchemin; Philippe Gros
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.